AtriCure Stock Price. Everything You Need To Know About The AtriCure Stock!
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,050 full-time employees. The company went IPO on 2005-08-05. The firm develops, manufactures and sells devices designed primarily for the surgical ablation of cardiac tissue, systems designed for the exclusion of the LAA and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers. Its ablation and left atrial appendage (LAA) management products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System.
AtriCure Stock Price. Everything You Need To Know About The AtriCure Stock! performance
- Employees 1050
- Company HQ Mason
- Website https://www.atricure.com
- ATRC Asset Type Common Stock
- ATRC Market Capitalization 1.1B
- Earnings Per Share -0.66
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, looking to expand your investment portfolio, AtriCure is a stock you should consider. AtriCure is a leading medical device company that specializes in innovative solutions for the treatment of atrial fibrillation and related conditions. With a strong track record in the healthcare sector, investing in AtriCure could provide long-term growth potential. To invest in AtriCure from Malaysia, Thailand, Indonesia, or Vietnam, you can utilize Zorion’s investment platform. Zorion offers real-time investment insights and recommendations to help you make informed decisions about your investment. Additionally, through educational resources and materials, Zorion can help you further your investment knowledge, ensuring you stay updated with the latest trends and strategies. Investing in AtriCure from Malaysia, Thailand, Indonesia, or Vietnam is now within your reach with Zorion’s user-friendly platform. Start your investment journey and explore the potential of this promising stock today.
